Zobrazeno 1 - 10
of 16
pro vyhledávání: '"David Vehlow"'
Autor:
Thomas Leonhard Loy, David Vehlow, Vivien Kauschke, Martin Müller, Christian Heiss, Katrin Susanne Lips
Publikováno v:
Molecules, Vol 25, Iss 18, p 4151 (2020)
Bone substitute materials loaded with mediators that stimulate fracture healing are demanded in the clinical treatment in trauma surgery and orthopedics. Brain-derived neurotrophic factor (BDNF) enhances the proliferation and differentiation of mesen
Externí odkaz:
https://doaj.org/article/1afdc8f64186455e941d756569892f73
Autor:
David Vehlow, Jeremy P. H. Wong, Birgit Urban, Janek Weißpflog, Annett Gebert, Matthias Schumacher, Michael Gelinsky, Manfred Stamm, Martin Müller
Publikováno v:
Pharmaceutics, Vol 12, Iss 9, p 799 (2020)
The proteasome inhibitor bortezomib (BZM) is one of the most potent anti-cancer drugs in the therapy of multiple myeloma. In this study, an adhesive drug delivery system (DDS) for BZM was developed. Therefore, we extended the present DDS concept of p
Externí odkaz:
https://doaj.org/article/2c787cb28ea143439c70aa275ed22fd0
Autor:
Janek Weißpflog, Alexander Gündel, David Vehlow, Christine Steinbach, Martin Müller, Regine Boldt, Simona Schwarz, Dana Schwarz
Publikováno v:
Molecules, Vol 25, Iss 11, p 2482 (2020)
The biopolymer chitosan is a very efficient adsorber material for the removal of heavy metal ions from aqueous solutions. Due to the solubility properties of chitosan it can be used as both a liquid adsorber and a solid flocculant for water treatment
Externí odkaz:
https://doaj.org/article/7208353163ea43df9c2884cde49d1da0
Autor:
Vivien Kauschke, Felix Maximilian Hessland, David Vehlow, Martin Müller, Christian Heiss, Katrin Susanne Lips
Publikováno v:
Molecules, Vol 24, Iss 12, p 2346 (2019)
Fracture treatment in osteoporotic patients is still challenging. Osteoporosis emerges when there is an imbalance between bone formation and resorption in favor of resorption by osteoclasts. Thus, new implant materials for osteoporotic fracture treat
Externí odkaz:
https://doaj.org/article/2986367474294303a0d9ca870ce3cdf0
Autor:
David Vehlow, Romy Schmidt, Annett Gebert, Maximilian Siebert, Katrin Susanne Lips, Martin Müller
Publikováno v:
Nanomaterials, Vol 6, Iss 3, p 53 (2016)
An improved interfacial drug delivery system (DDS) based on polyelectrolyte complex (PEC) coatings with controlled drug loading and improved release performance was elaborated. The cationic homopolypeptide poly(l-lysine) (PLL) was complexed with a mi
Externí odkaz:
https://doaj.org/article/4f418b855361472189e62451c85a9cc1
Autor:
Philipp Zimmermann, Kornelia Schlenstedt, Simona Schwarz, David Vehlow, Marit Blanke, Andreas Fery, Jürgen Nagel
Publikováno v:
ACS Applied Polymer Materials. 4:5189-5198
Autor:
Ulrich Scheler, Simona Schwarz, Susanne Boye, Benjamin Kohn, David Vehlow, Janek Weißpflog, Martin Müller
Publikováno v:
International Journal of Biological Macromolecules. 171:242-261
In recent years, chitosan has attracted considerable interest in many fields due to its sufficient charge density under biological, non-hazardous conditions. Since chitosan originates from natural resources and has two different monomer units, its ch
Autor:
Jeremy P H Wong, David Vehlow, Michael Gelinsky, Annett Gebert, Matthias Schumacher, Martin Müller, Birgit Urban, Manfred Stamm, Janek Weißpflog
Publikováno v:
Pharmaceutics, Vol 12, Iss 799, p 799 (2020)
Pharmaceutics, 12(9):799. Multidisciplinary Digital Publishing Institute (MDPI)
Pharmaceutics
Volume 12
Issue 9
Pharmaceutics, 12(9):799. Multidisciplinary Digital Publishing Institute (MDPI)
Pharmaceutics
Volume 12
Issue 9
The proteasome inhibitor bortezomib (BZM) is one of the most potent anti-cancer drugs in the therapy of multiple myeloma. In this study, an adhesive drug delivery system (DDS) for BZM was developed. Therefore, we extended the present DDS concept of p
Publikováno v:
Current Pharmaceutical Design. 24:1341-1348
Background: In this contribution an overview is given on own work concerning drug loaded Polyelectrolyte Complex (PEC) Nanoparticles (NP) used to functionalize Bone Substitute Materials (BSM) for the therapy of bone defects associated with systemic b
Publikováno v:
Colloid and Polymer Science. 295:1187-1199
Thermoaddressable coatings based on poly(N-isopropylacrylamide-co-acrylic acid) (PNIPAM-AA) complexed with ethylenediamine-modified cellulose (EDAC) are reported eluting bone therapeutic zoledronate (ZOL) in defined amounts. At T = 25 °C, phase-sepa